文献速递慢阻肺

ADAM8:慢性阻塞性肺疾病中的新型保护性蛋白酶

A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

研究探讨ADAM8在COPD中的作用,发现COPD患者和吸烟小鼠肺内ADAM8表达降低,而Adam8缺失小鼠在香烟暴露后出现更严重的肺气肿、气道黏液细胞化生和炎症,机制涉及巨噬细胞凋亡和EGFR脱落减少,提示增加ADAM8可能治疗COPD。

要点

  • COPD患者肺内ADAM8表达降低,但血浆、痰和BALF中水平与对照相似。
  • Adam8缺失加重香烟诱导的小鼠肺气肿、黏液细胞化生和炎症。
  • ADAM8通过促进巨噬细胞凋亡和脱落EGFR减少黏液表达发挥保护作用。

核心结论

  • Adam8缺失加重香烟诱导的肺部炎症、肺气肿和气道黏液细胞化生。
  • 增加或延长肺内ADAM8表达可能对COPD有治疗作用。

研究设计与样本

  • 比较COPD患者、吸烟者和非吸烟者肺、痰、血浆和/或BALF中ADAM8水平。
  • 比较香烟暴露的野生型与Adam8-/-小鼠的COPD样肺病理。
  • 进行Adam8骨髓嵌合体研究确定细胞来源。

主要发现

  • COPD患者肺巨噬细胞、肺泡和支气管上皮细胞ADAM8免疫染色较对照减少。
  • 香烟暴露野生型小鼠肺ADAM8免疫染色较空气暴露减少。
  • COPD患者血浆、痰和BALF中ADAM8水平与对照相似。
  • 香烟暴露Adam8-/-小鼠较野生型有更明显的气腔扩大和气道黏液细胞化生,但小气道纤维化相似。
  • 香烟暴露Adam8-/-小鼠肺巨噬细胞计数、氧化应激水平和肺泡间隔细胞死亡率较高,肺泡间隔细胞增殖率和BALF可溶性EGFR水平较低。

关键数值与推荐

  • 人ADAM8在体外从支气管上皮细胞蛋白水解脱落EGFR,减少黏蛋白表达。
  • Adam8在白细胞和肺实质细胞中的缺陷均导致Adam8-/-小鼠COPD样病变加重。

临床怎么用

  • ADAM8可能作为COPD的潜在治疗靶点,但需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: ADAM8 (a disintegrin and metalloproteinase domain-8) is expressed by leukocytes and epithelial cells in health, but its contribution to the pathogenesis of chronic obstructive pulmonary disease (COPD) is unknown. OBJECTIVES: To determine whether the expression of ADAM8 is increased in the lungs of patients with COPD and cigarette smoke (CS)-exposed mice, and whether ADAM8 promotes the development of COPD. METHODS: ADAM8 levels were measured in lung, sputum, plasma, and/or BAL fluid samples from patients with COPD, smokers, and nonsmokers, and wild-type (WT) mice exposed to CS versus air. COPD-like lung pathologies were compared in CS-exposed WT versus Adam8-/- mice. MEASUREMENTS AND MAIN RESULTS: ADAM8 immunostaining was reduced in macrophages, and alveolar and bronchial epithelial cells in the lungs of patients with COPD versus control subjects, and CS- versus air-exposed WT mice. ADAM8 levels were similar in plasma, sputum, and BAL fluid samples from patients with COPD and control subjects. CS-exposed Adam8-/- mice had greater airspace enlargement and airway mucus cell metaplasia than WT mice, but similar small airway fibrosis. CS-exposed Adam8-/- mice had higher lung macrophage counts, oxidative stress levels, and alveolar septal cell death rates, but lower alveolar septal cell proliferation rates and soluble epidermal growth factor receptor BAL fluid levels than WT mice. Adam8 deficiency increased lung inflammation by reducing CS-induced activation of the intrinsic apoptosis pathway in macrophages. Human ADAM8 proteolytically shed the epidermal growth factor receptor from bronchial epithelial cells to reduce mucin expression in vitro. Adam8 bone marrow chimera studies revealed that Adam8 deficiency in leukocytes and lung parenchymal cells contributed to the exaggerated COPD-like disease in Adam8-/- mice. CONCLUSIONS: Adam8 deficiency increases CS-induced lung inflammation, emphysema, and airway mucus cell metaplasia. Strategies that increase or prolong ADAM8's expression in the lung may have therapeutic efficacy in COPD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Polverino F, Rojas-Quintero J, Wang X, et al. A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018. PMID: 29750543. doi:10.1164/rccm.201707-1331OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。